Seller record · Telehealth service
Medsol RX
Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the packages page, the product pages, the answers or the terms.
At a glance
Medsol RXTelehealth service
- Price
- Semaglutide $169 the first month, then $199 a month; tirzepatide $239, then $259
- Sells
- compounded semaglutide injections, compounded tirzepatide injections, and 12 more
- FDA letters
- None on file
Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.
A Florida telehealth weight loss clinic serving patients nationwide, selling compounded semaglutide and tirzepatide injections, oral semaglutide, microdose plans and branded Ozempic and Zepbound pens with care coaching, plus sermorelin, NAD+ and other wellness injections. Care starts with an online assessment and a telehealth consultation with an outside clinician network, and its terms name four partner pharmacies with street addresses.
Operating entity No legal entity name appears in the footer, in the terms and conditions, in the privacy policy or in the subscription and refund policy, which name the company only as Medsol RX.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Medsol RX's website; Medsol RX's FAQ |
| S2 | Prescription gating | PASS | Medsol RX's website; Medsol RX's subscription services cancellation and refund policy |
| S3 | Pharmacy identification | PASS | Medsol RX's terms and conditions |
| S4 | Compounding disclosure | PASS | Medsol RX's website; Medsol RX's FAQ |
| S5 | Analytical documentation | FAIL | Medsol RX's packages page; Medsol RX's FAQ; Medsol RX's terms and conditions |
| S6 | Business address | PASS | Medsol RX's privacy policy; Medsol RX's terms and conditions |
| S7 | Price disclosure | PASS | Medsol RX's packages page; Medsol RX's semaglutide page; Medsol RX's tirzepatide page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, compounded oral semaglutide, tirzepatide orally disintegrating tablets, GLP-1 microdose plans, Ozempic, Zepbound, sermorelin, NAD+, B12 MIC injections, glutathione, L-carnitine, Lipo-C, methylene blue.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathione
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.